Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function

Journal of Hypertension

Volumn 20, Issue SUPPL. 5, 2002, Pages

  Esler, Murray ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Arterial compliance; High blood pressure; Isolated systolic hypertension; Noradrenaline; Presynaptic angiotensin receptors; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; NORADRENALIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; ESSENTIAL HYPERTENSION; HYPERTENSION; ISOTOPE DILUTION ASSAY; NONHUMAN; NORADRENALIN RELEASE; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; ADRENERGIC SYSTEM; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; INSULIN RESISTANCE; PHYSIOLOGY; REVIEW; SECRETION; SYSTOLE;

ANGIOTENSINS; ANIMALS; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; INSULIN RESISTANCE; NOREPINEPHRINE; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM; SYSTOLE;

EID: 0036600344     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200212000-00001     Document Type: Conference Paper

References (37)

1. The assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover
2. How to assess sympathetic activity in humans
3. Sympathetic tone restrains arterial distensibility of healthy and atherosclerotic subjects
4. The 'adrenaline hypothesis' of hypertension revisited: Evidence for adrenaline release from the heart of patients with essential hypertension
5. Phenotypic evidence of faulty neuronal noradrenaline reuptake in essential hypertension
6. Neural mechanisms in human obesity-related hypertension
7. Sympathetic neural control of the kidney in hypertension
8. Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension
9. Mild high-renin essential hypertension: A neurogenic human hypertension?
10. U-shaped relation between age and 24-hour pulse pressure in hypertensive men
11. Reduced postprandial skeletal muscle blood flow contributes to glucose intolerance in human obesity
12. The interconnection between sympathetics, microcirculation and insulin resistance in hypertension
13. Heart rate and the cardiovascular risk
14. Adrenergic effects on the biology of the adult mammalian cardiocyte
15. Evidence for a selective increase in resting cardiac sympathetic activity in some patients suffering sustained out of hospital ventricular arrhythmias
16. The determinants of plasma-renin activity in essential hypertension
17. Evidence for a central mechanism in angiotensin induced hypertension
18. Brain angiotensin: On the way to becoming a well-studied neuropeptide system
19. 1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla
20. Role of angiotensin II receptor subtypes in mediating the sympathoexcitatory effects of exogenous and endogenous angiotensin peptides in the rostral ventrolateral medulla of the rabbit
21. Influence of brain renin-angiotensin system on renal sympathetic and cardiac baroreflexes in conscious rabbits
22. Effect of endogenous angiotensin II on renal nerve activity and its arterial baroreflex regulation
23. 1 receptors in the central control of sympathetic vasomotor function
24. Baroreceptor-independent renal nerve inhibition by intracerebroventricular angiotensin II in conscious sheep
25. Brain angiotensinergic pathways mediate renal nerve inhibition by central hypertonic NaCl
26. Effect of central endogenous angiotensin II on sympathetic activation induced by hypoxia
27. 1 receptor blockade abolishes the reflex sympatho-excitatory response to adenosine
28. 1 receptor blockade and the sympathoadrenal response to insulin-induced hypoglycemia in humans
29. The influence of captopril on the epinephrine response to insulin-induced hypoglycemia in humans. The interaction between the renin-angiotensin system and the sympathetic nervous system
30. Inhibition of sympathetic outflow by the angiotensin II receptor, eprosartan, but not by losartan, valsartan or irbesartan: Relationship to differences in prejunctional angiotensin II receptor blockade
31. Influence of the renin-angiotensin system on sympathetic neurotransmission in canine skeletal muscle in vivo
32. Beta 2-adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria
33. Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm
34. Beta-adrenergic, angiotensin II, and bradykinin receptors enhance neurotransmission in human kidney
35. Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: Comparison between valsartan, candesartan, eprosartan and embusartan
36. Pharmacology of eprosartan, an angiotensin II receptor antagonist: Exploring hypothesis from clinical data